US2016168637A1PendingUtilityA1

Genetic markers of mental illness

58
Assignee: SUREGENE LLCPriority: Jan 17, 2008Filed: May 4, 2015Published: Jun 16, 2016
Est. expiryJan 17, 2028(~1.5 yrs left)· nominal 20-yr term from priority
Inventors:Mark David BrennanTimothy Lynn Ramsey
C12Q 2600/172C12Q 1/6883C12Q 2600/118A61K 31/5513A61K 31/5415A61K 31/554G16H 70/40A61K 31/551G16H 70/60C12Q 2600/106A61K 31/496G16B 20/00C12Q 2600/156C12Q 2600/158A61K 31/519G16B 20/20Y02A90/10
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention relates to genetic markers of mental illness, e.g., schizophrenia (SZ), and methods of use thereof.

Claims

exact text as granted — not AI-modified
1 . A method of obtaining information regarding a human subject's risk of developing schizophrenia (SZ) the method comprising:
 obtaining a test haplotype for the subject by determining the genotype of at least one test marker listed in Table B, or a test marker that lies between a pair of delimiting markers listed in Table A and that is in linkage disequilibrium with markers listed in Table B, wherein the test haplotype indicates the subject's risk of developing SZ.   
     
     
         2 .- 47 . (canceled)

Join the waitlist — get patent alerts

Track US2016168637A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.